GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,035,000 | -1.1% | 4,766 | -47.3% | 0.00% | -25.0% |
Q4 2020 | $1,047,000 | +17.5% | 9,048 | -1.6% | 0.00% | 0.0% |
Q3 2020 | $891,000 | -15.4% | 9,199 | +6.5% | 0.00% | -33.3% |
Q2 2020 | $1,053,000 | +21.9% | 8,635 | -12.5% | 0.01% | 0.0% |
Q1 2020 | $864,000 | -15.1% | 9,864 | +1.0% | 0.01% | 0.0% |
Q4 2019 | $1,018,000 | +22.4% | 9,767 | +35.2% | 0.01% | +20.0% |
Q3 2019 | $832,000 | -27.8% | 7,223 | +7.6% | 0.01% | -28.6% |
Q2 2019 | $1,152,000 | +45.5% | 6,712 | +43.0% | 0.01% | +40.0% |
Q1 2019 | $792,000 | -8.7% | 4,693 | -80.8% | 0.01% | -16.7% |
Q4 2018 | $867,000 | -34.3% | 24,381 | -2.8% | 0.01% | -33.3% |
Q3 2018 | $1,319,000 | +46.6% | 25,078 | +90.8% | 0.01% | +28.6% |
Q2 2018 | $900,000 | +118.4% | 13,147 | +258.6% | 0.01% | +133.3% |
Q1 2018 | $412,000 | -1.4% | 3,666 | +15.9% | 0.00% | 0.0% |
Q4 2017 | $418,000 | +63.9% | 3,162 | +26.2% | 0.00% | +50.0% |
Q3 2017 | $255,000 | -12.1% | 2,506 | -12.5% | 0.00% | -33.3% |
Q2 2017 | $290,000 | +17.4% | 2,865 | +40.2% | 0.00% | +50.0% |
Q1 2017 | $247,000 | +18.8% | 2,044 | +10.3% | 0.00% | 0.0% |
Q4 2016 | $208,000 | +2.5% | 1,853 | -15.7% | 0.00% | -33.3% |
Q2 2016 | $203,000 | +0.5% | 2,199 | -26.4% | 0.00% | +50.0% |
Q4 2015 | $202,000 | -11.4% | 2,988 | +23.9% | 0.00% | -33.3% |
Q3 2015 | $228,000 | -52.1% | 2,412 | -37.8% | 0.00% | -62.5% |
Q2 2015 | $476,000 | +41.2% | 3,876 | +4.8% | 0.01% | +60.0% |
Q1 2015 | $337,000 | +17.0% | 3,698 | +3.6% | 0.01% | 0.0% |
Q3 2014 | $288,000 | – | 3,568 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|